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Abstract 
Aims: Loss of pericytes in the early phases of diabetic retinopathy (DR) may disrupt their stable association 
with endothelial cells (EC), leading to EC proliferation and, eventually, angiogenesis. Extracellular vesicles 
(EV) are small membrane particles derived from different cells which contain biologically active proteins and 
RNA and are known to promote phenotypic changes in target cells. In diabetic-like conditions, EV derived 
from MSC may play a role in vessel destabilization by interfering with the strict interactions between 
EC/pericytes and pericyte/extracellular matrix.  
Methods: We examined the behaviour of retinal pericytes exposed to EV derived from MSC cultured in 
physiological and diabetic-like conditions (high glucose and/or hypoxia). 
Results: MSC-derived EV are able to enter the pericytes, cause their detachment and migration from the 
substrate, and increase blood-barrier permeability. Moreover, EV added to EC/pericytes co-cultures in 
Matrigel promote in vitro angiogenesis. These effects may be mediated by matrix metalloproteinase-2, 
expressed by both EV and EV-stimulated pericytes, and are exacerbated if MSC are previously cultured in 
conditions (high glucose and/or hypoxia) mimicking the diabetic microvascular milieu. 
Conclusions: We confirm that MSC-derived EV contribute to angiogenesis, showing that they may not only 
exert a direct stimulus to EC proliferation, but also induce pericyte detachment, thus leaving EC free to 
proliferate. In addition, we demonstrate a possible link between EV and the early stages of the pathogenesis 
of DR. Diabetic-like conditions may influence vessel remodelling during angiogenesis through EV paracrine 
signalling.  
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Introduction 
Micro- and macrovascular alterations are key features of the diabetic condition. However, while the retina 
may be affected by increased revascularization, leading to proliferative diabetic retinopathy (DR), other 
organs show a marked inhibition of angiogenesis, which in turn leads to peripheral vascular and coronary 
heart disease (the angiogenic paradox in diabetes) [1]. 
Pericytes and their interactions with endothelial cells (EC) in the vessel wall have come into focus as central 
processes in the regulation of vessel formation, stabilization and remodelling [2], thus playing a key role in 
the pathogenesis of such vascular abnormalities as diabetic microangiopathy (in particular DR), 
hypertension, stroke, tumour formation and neurodegenerative diseases [3, 4]. If EC are exposed to the 
complex signals deriving from the blood flow, pericytes receive, and transmit to the endothelium, signals from 
the surrounding tissues.  
Mesenchymal stem cells (MSC) are ubiquitous pluripotent stem cells, whose presence in human eye tissues 
such as retrocorneal membranes, vitreous, orbital adipose tissue, has been ascertained [5]. A possible 
contribution of MSC to the physiological and pharmacological repair of tissue damage in several organs has 
been postulated [5-7]. This may be mediated through transfer of genetic information by extracellular vesicles 
(EV) [8-11], small membrane particles which include exosomes and microvesicles [12] and represent one of 
the most promising paracrine signalling pathways. They are released by several cell types in physiological 
conditions and in response to stress or pathological stimuli [13] and are able to regulate cell migration, 
proliferation and differentiation, as they contain several biologically active molecules [13-15]. In particular, an 
important role of EV in the induction of angiogenesis has been suggested [12-15]. 
EV have been described as potential biomarkers for metabolic diseases, in particular type II diabetes [13]. 
Circulating EV concentration is increased in diabetic animal models [13] and in subjects with type II diabetes 
[16] or the metabolic syndrome [17, 18], compared with healthy controls. Monocyte-derived EV have been 
found increased in patients with diabetic nephropathy and could be markers of microangiopathy [19]. 
Pericyte survival depends also on their interactions with the extracellular matrix (ECM), whose proteins are 
susceptible to rapid degradation by metalloproteinases (MMP). Hyperglycaemia-induced upregulation of 
MMP-2 has been demonstrated in the arterial vasculature in vivo [20] and, in vitro, in several cell types [21, 
22] including pericytes [23]. 
Our working hypothesis is that, in diabetic-like conditions, EV derived from MSC may play a role in vessel 
destabilization by interfering with the strict EC/pericytes and pericyte/ECM interactions. In particular, EV 
might stimulate pericyte migration and their loss of contact with EC, thus influencing abnormal angiogenesis. 
Hence, this study was aimed at examining the behaviour of retinal pericytes exposed to EV derived from 
MSC cultured in physiological and diabetic-like conditions (hyperglycaemia and/or hypoxia) and to evaluate 
the possible role of MMP-2. 
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Materials and Methods 
Reagents were purchased by Sigma-Aldrich, unless otherwise stated. 
Cell cultures 
Human retinal pericytes (HRP) were immortalized in our laboratory [24]. Human bone marrow and adipose 
MSC, and human microvascular EC (HMEC) were purchased from Lonza. HRP and MSC were grown in 
DMEM + 10%FCS, HMEC in EBM-2 growth medium (Lonza) supplemented with angiogenic factors, 
according to the instructions. 
 
EV isolation  
MSC were cultured for 8 days in physiological (5.6 mmol/L, NG) or high glucose (28.0 mmol/L, HG). Hypoxic 
conditions were obtained by keeping cultures in 5%CO2 / 94%N2 /1%O2 gas mixture for the last 24 hrs (NG 
hypo, HG hypo). MSC were serum-deprived 24 hrs prior to EV isolation. 
Cell debris and apoptotic bodies were removed from the supernatants by centrifugation for 30’ at 3,000 and 
10,000g respectively, then EV were isolated by a further ultracentrifugation at 100,000g for 3 hrs at 4°C. 
They were used immediately or stored at −80°C in DM EM + 5%DMSO. No differences in biological activity 
were observed between fresh and stored EV. EV protein content was quantified by Bradford method, and 
their size distribution and number using a NanoSight LM10, through the Nanoparticle Tracking Analysis 
software. For all experiments an EV concentration correspondent to that in MSC supernatants (1×1011 ± 
1×103 EV/ml, corresponding to 1×105 ± 1×102 EV/cell) was used. 
To investigate EV uptake by HRP, EV were labelled with the red fluorescent aliphatic chromophore PKH26 
dye, which intercalates into lipid bilayers. HRP were stained with a FITC-conjugate anti-α-smooth muscle 
actin, and nuclei counterstained with DAPI. Confocal microscopy was performed using a Zeiss microscope, 
model LSM 5 PASCAL (Jena). 
For MMP inhibition studies, EV were pre-incubated with 1 µmol/L batimastat (Abcam) for 15 min prior to 
addition to HRP. 
 
Cell survival variables 
Cell were counted in Bürker chambers after Trypan blue staining by 2 individual operators. Apoptosis was 
evaluated by the DeadEnd Colorimetric TUNEL System (Promega). Positive controls were HRP treated with 
30 U/ml RNase-free DNase I (Roche), while negative control cells were incubated without the Terminal 
Deoxynucleotidyl Transferase. Images were taken under a Leica DM 2000 microscope, equipped with a 
Leica DFC 320 camera and Leica QWin Plus 2003 digital processing and analysis software. 
 
Migration 
HRP migration was investigated through a MicroImage analysis system (Casti Imaging), by digitally saving 
images of the same fields at 30-min intervals over a 12hr period. Migration tracks were generated by marking 
the position of the nuclei of individual cells on each image [25]. 
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Permeability 
40,000 EC/well were seeded on the inner surface of 0.45-µm pore-transwell inserts (Corning) and left to 
adhere for 24 hrs. 40,000 HRP were subsequently added onto the same insert, as previously described [26]. 
After another 24 hrs, inserts were washed and moved to clean the wells. 600 µl DMEM without red phenol 
and FCS were added to the lower chamber, while 200 µl of the same medium supplemented with EV was 
added into the inserts. After 2 hrs, FITC-dextran (100 µg/ml final concentration) was added into the upper 
chamber, and fluorescence measured in the lower chamber after another 30’, 1, 2, 3, 4 and 24hrs, through a 
Victor-3 Multilabel Plate Reader (Perkin Elmer).  
Vessel-like formation assay 
15,000 HRP and 15,000 EC/well were seeded together onto Matrigel-coated 24-well plates and cultured in 
serum-deprived DMEM added with EV. Control cultures were obtained seeding 30,000 HRP or 30,000 EC 
alone in Matrigel-coated wells. 
After 24 and 48 hr incubation, phase-contrast images were recorded, and the total length of the network 
structures measured using the MicroImage analysis system [27] in five random fields and expressed as ratio 
of control without EV. 
Zymography 
Zymography was performed on EV (3 µg proteins/well) and HRP conditioned media (30 µl/well), using Ready 
Zymogram Precast Gels (Biorad) (10%) copolymerized with 1 mg/ml gelatine. Samples were mixed with 
Laemmli’s buffer without β-mercaptoethanol and incubated for 10’ at RT. After electrophoresis, gels were 
washed twice for 30’ in 2.5% Triton X-100 at RT, incubated ON in collagenase buffer (50 mM Tris-HCl pH7.5, 
10 mM CaCl2, 150 mM NaCl) at 37°C, and then stained with Cooma ssie brilliant blue. Gelatinolytic activity 
was visualized as clear bands on a blue background, signal strengths were quantified using a densitometric 
software (1D Image Analysis System, Kodak). 
Statistical analysis 
Results are mean ± SD of 5 independent experiments, normalized against control (NG cultures without EV). 
Statistical comparisons among groups were carried out by two-tailed Student’s t-test for paired data or 
Wilcoxon’s Signed Ranks test, as appropriate. Results were considered significant for p≤0.05. SPSS 
software version 22.0 (IBM) was used for statistical analysis. 
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Results  
1. EV are internalized into human retinal pericytes (HRP) 
EV were collected from the supernatant of bone marrow-derived MSC cultured in the above described 
conditions (NG, HG, NG hypo, HG hypo), to mimic the diabetic milieu, especially of the retina, where 
pericytes play a major role in the development of the microvascular disease and hypoxia is a recurrent 
condition. 
NanoSight analysis showed super-imposable concentrations and similar mean size for EV obtained in all 
conditions (NG: 128±49 nm, HG: 148±41 nm, NG hypo: 138±43 nm, HG hypo: 140±44 nm), while agarose 
gel electrophoresis demonstrated that EV contain RNA, but not DNA. 
EV were able to enter pericytes already after 1hr incubation and locate inside the cytoplasm, as shown by 
confocal microscopy, when PKH26-marked EV were added to HRP (Fig.1). No differences in HRP 
internalization was observed using EV obtained in different conditions.  
2. MSC-derived EV stimulate HRP detachment and migration 
EV were added to sub-confluent HRP cultures and the number of HRP still attached was determined at 0, 2, 
4, 6 and 24 hrs. We observed a time-dependent detachment of HRP induced by EV obtained in all conditions 
(Fig. 2a), the major effect occurring after 2 hrs. Detachment was higher when HRP were exposed to EV 
obtained in diabetic-like conditions. HRP number after 2 hrs exposure to EV obtained in NG (NG-EV) was -
31.8% in comparison with control (HRP not exposed to EV, p<0.05); HG-EV: -62.9% (p<0.05 vs control and 
NG-EV), NG hypo-EV: -48.8% (p<0.05 vs control and NG-EV), HG hypo-EV: -66.2% (p<0.05 vs control and 
NG-EV) (Fig. 2b). These results indicate that EV exposure leads to pericyte detachment from their substrate, 
and that diabetic-like conditions exacerbate such effect. 
Increased HRP motility was observed after addition of EV, particularly those obtained in hypoxia (Fig. 2c). 
The higher increase was observed after 1 hr EV exposure in all experimental conditions: NG-EV +37.1% vs 
control (NS), HG-EV +43.6% (p<0.05), NG hypo-EV +47.0% (p<0.05), HG hypo-EV +56.0% (p<0.05) (Fig. 
2d). This suggests that exposure to EV may enhance HRP migration. 
To evaluate if these effects were tissue-specific, we checked our findings on HRP detachment using, in 
addition to EV from bone marrow MSC, EV extracted from adipose MSC and from EC, in physiological 
conditions (NG). A significant decrease in the number of pericytes exposed to EV from both types of MSC 
was observed. After 2 hrs, bone marrow MSC-EV: -23.6% (p<0.005 vs control), adipose MSC-EV: -17.4%, 
(p<0.005), while EV from EC had no effect at all. Interestingly, after 24 hrs HRP treated with HMEC-EV were 
significantly increased in number (+5.0% vs untreated HRP, p<0.005) (Fig. 2e). Hence, we suppose that EV 
effects on pericyte detachment are common to MSC of different tissue-origin, while EC-derived MSC have an 
opposite effect, probably due to in vivo tight interactions with pericytes. 
3. EV stimulation does not change survival parameters in HRP 
HRP released in the supernatant, i.e. the cells that had detached after EV stimulation, were collected and 
seeded in new plates, where they were able to re-attach. The percentage of dead cells, measured by Trypan 
blue staining, was <10%. TUNEL assay performed on these new cultures showed no signs of apoptosis (Fig. 
3), confirming that detached pericytes maintain their viability. 
7 
 
4. EV increase blood-barrier permeability 
FITC filtration through our blood-barrier model was augmented by exposure to EV (Fig. 4a), the highest 
percentage increase occurring after 6 hrs of EV exposure (2 hrs pre-treatment + 4 hrs FITC).  Permeability 
was further increased when co-cultures were exposed to EV obtained in hyperglycaemic and/or hypoxic 
conditions: NG-EV +19.8% (p<0.05 vs control without EV), HG-EV +33.8% (p<0.005 vs control, p<0.05 vs 
NG-EV), NG hypo-EV +25.6% (p<0.05 vs control, p=0.000 vs NG-EV), HG hypo-EV +35.8% (p<0.05 vs 
control and NG-EV) (Fig. 4b). Therefore we hypothesize that EV (especially those in diabetic-like conditions) 
are able to enhance the retinal blood-barrier permeability. 
5. EV enhance in vitro formation of vessel-like structures by HRP/EC co-cultures 
Addition of EV to HRP/EC co-cultures on Matrigel promoted the formation of vessel-like structures. In control 
wells, after 48 hrs in serum-free medium, EC and HRP grown separately were simply sub-confluent and no 
vessel-like structures were present. On the contrary, in wells where EC and HRP had been seeded together, 
vessel-like structures had formed. EV addition to EC/HRP co-cultures enhanced the number of newly-formed 
structures in all cases, in particular with EV obtained in hyperglycaemic conditions (+34.6% vs control 
without EV, p<0.05), while hypoxia together with HG had a synergist effect (+54.3%, p<0.05 vs control and 
HG alone) (Fig. 5).  
6. EV action on HRP is mediated by MMP-2 
EV from MSC in all experimental conditions contained the active form of MMP-2 (62 kDa) (Fig. 6a), which on 
the contrary was scarcely expressed by EC-derived EV (Fig. 6b). In addition, after 48 hr EV stimulation, the 
expression of active MMP-2 in HRP supernatants was significantly increased in comparison with untreated 
controls (NG-EV: +51.1%, p<0.05; HG-EV:+48.0, p<0.005; NG hypo-EV: +75.8%, p<0.05; HG hypo-EV: 
+37.9%, p<0.05) (Fig. 6c). Consistently with the above results (Fig. 6b), supernatants of HRP treated with 
EC-derived EV showed very low MMP-2 expression (Fig. 6d). 
To check the role of MMP-2, we pre-treated EV with batimastat, a broad-spectrum MMP inhibitor, whose 
effect on MMP-2 has been described [28], and subsequently exposed HRP to them. HRP number decreased 
after 2hr incubation with untreated EV in all conditions, consistently with previous observations described in 
Fig.2 a-b, while pre-incubation of EV with batimastat completely reverted their effect on pericyte detachment 
in all conditions, thus confirming MMP involvement in pericyte destabilization (Fig. 6e). 
Finally, to check that batimastat does not impede EV internalization into HRP, we exposed HRP to PKH26- 
stained EV obtained in all diabetic-like conditions, with or without pre-treatment with batimastat. We found no 
difference in EV internalization in all cases. Figure 6 f-g show sample images of HRP exposed to EV (f) and 
batimastat pre-treated EV (g). 
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Discussion 
Our results show that MSC-derived EV are able to enter the pericytes, causing their detachment from the 
substrate and migration, possibly contributing to increased blood-barrier permeability in vivo. Moreover, EV 
stimulate angiogenesis in vitro. These effects are mediated by MMP-2, expressed by both EV and EV-
stimulated pericytes.  
Previous studies had demonstrated that EV derived from MSC of different origin induce angiogenesis, 
contributing to tissue remodelling after injury [12, 29]. However, what is a beneficial effect in most tissues 
and in several diseases, may not be necessarily the same in others. A sort of angiogenesis paradox 
operates in diabetes: while inappropriate neovascularization may occur in the retina, leading to proliferative 
DR, in other districts marked inhibition of angiogenesis may lead to peripheral vascular and coronary heart 
disease [1]. 
In this work we demonstrate that EV are able to induce angiogenesis not only through direct stimulation of 
EC growth, but also indirectly, inducing pericyte detachment and migration. This may lead to a lack of control 
on EC proliferation and thus to angiogenesis. This is confirmed by the finding that addition of EV to 
EC/pericytes co-cultures in Matrigel increases the number of newly-formed vessels. 
Loss of pericytes, together with thickening of the basement membrane, is considered hallmarks of the early 
phases in the pathogenesis of DR, with major consequences on vessel remodelling [2, 4, 30]. Pericytes 
regulate capillary tone and pressure and play a major role in EC proliferation [31]: when their control fails, 
endothelium enters an angiogenic process, which may lead to proliferative DR [30]. Systemic and local 
hypertension, hyperglycaemia, advanced glycation end-product (AGE) formation and hypoxia can induce 
angiogenesis and retinal neovascularisation. Another hallmark of DR is increased vascular permeability, also 
linked to early loss of pericytes [29]. In this paper, we show increased filtration through EC/pericytes bi-layers 
exposed to EV. 
Consistently with the hypothesized role of EV in the pathogenesis of DR, the above described effects of 
MSC-derived EV exposure on pericytes and EC/pericytes co-cultures are exacerbated if MSC are previously 
cultured in conditions (high glucose and/or hypoxia) that mimic the diabetic microvascular milieu. 
It is generally acknowledged that hypoxia, a cause of proliferative DR [30], is also a mediator of tumour 
development and aggressiveness [32], through the induction of growth factors, proteases and cytokines that 
leads to angiogenesis [33]. Recent data show that EV derived from glioblastoma cells cultured in hypoxic 
conditions induce angiogenesis ex vivo and in vitro through phenotypic EC modulation, and EC treated with 
glioblastoma cell-derived EV in hypoxia stimulate pericyte migration [32]. A role for hypoxia and 
inflammation, but not for high glucose, has been claimed for the altered protein and RNA content of EC-
released EV in stress conditions [34]. Pre-treatment of cultured mesangial cells with high glucose has been 
shown to increase miR-145 content in mesangial cells-derived EV [35]. 
However, a link between hyperglycaemic-like conditions and increased angiogenic potential of EV had not 
been hypothesized so far. In our experimental setting, we show that pericyte detachment from the substrate 
and permeability through EC/pericyte bi-layers is increased to a greater extent when EV are obtained from 
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MSC pre-cultured in high glucose and/or hypoxia conditions, while vessel formation in vitro seems to be 
increased by hyperglycaemic-like conditions, more than hypoxia.  
Pericytes detached from their substrate following EV stimulation maintain their viability, as they were able to 
re-attach to new culture substrate and did not undergo apoptosis. Since pericytes are necessary for the 
stabilization of newly-formed vessels during angiogenesis [36], we hypothesize that pericytes detached from 
old vessels following EV stimulation might be able to migrate to other districts, possibly to stabilize new 
vessels, consistently with previous observations [37].  
We also demonstrate that EV-induced pericyte detachment is specific to EV derived from MSC, as EV 
extracted from EC supernatants not only showed no effect, but seemed to increase pericyte number. This is 
confirmed by our finding of a lower content of MMP-2 in EC-EV in comparison with MSC-derived ones, as 
well as in supernatants of HRP exposed to them, and it is consistent with the fact that in vivo, especially in 
the retina, pericytes and EC live in tight contact and exert control on each other proliferation [31]. 
MMP are a class of enzymes which play a crucial role in angiogenesis: they proteolytically cleave several 
ECM components, determining release of pericytes and loosening of EC/ECM bounds, thus facilitating EC 
colonization [38]. MMP expression is usually low in physiological conditions, but is strongly up-regulated 
when ECM remodelling is required, such as in tumour invasion [39]. Hyperglycaemia-induced upregulation of 
MMP-2 has been demonstrated in several cell types [20-22], including pericytes [23]. Consistently with 
previous data [12], EV extracted from MSC in our lab strongly express MMP-2, while those extracted from 
EC scarcely do. Moreover, exposure of pericytes to MSC-derived, but not EC-derived, EV increase MMP-2 
expression, and this may explain their detachment from the substrate, when exposed to EV stimulation. The 
key-role of MMP-2 in our findings is confirmed by the fact that its inhibition by pre-incubating EV in 
physiological and pathological conditions with the MMP-inhibitor batimastat completely reverted EV effect on 
pericyte detachment.  
In conclusion, we confirm the contribution of MSC-derived EV to angiogenesis, showing that they may not 
only constitute a direct stimulus to EC proliferation, but also induce pericyte detachment, leaving EC free to 
proliferate. In addition, we demonstrate, for the first time in our knowledge, a possible link between 
extracellular vesicles and the early stages of DR. We can therefore hypothesize that diabetic-like conditions 
may influence vessel stabilization during angiogenesis through EV paracrine signalling. However, studies are 
needed to further investigate the molecular mechanisms involved in these new findings. 
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Fig. 1 EV internalize into HRP a) control: anti-α-smooth muscle actin and DAPI-stained HRP (green and 
blue, respectively) without EV; b) HRP incubated for 2 and c) 4 hrs with PKH26-stained EV (red) 
 
Fig. 2 MSC-derived EV stimulate HRP detachment and migration a) time-course response of HRP to EV 
stimulation: number of HRP still attached to the well, percentages of control (HRP cultures without EV); b) 
HRP number after 2 hr EV incubation, percentages of control, *=p<0.05 vs control, $ = p<0.05 vs cultures 
treated with EV obtained in physiological conditions (NG-EV); c) HRP migration following EV stimulation, 
time-course, µm/hr; d) HRP migration after 1 hr EV incubation, *=p<0.05 vs control; e) HRP number after 2 
and 24 hr incubation with EV derived from bone-marrow MSC (light grey bar), adipose MSC (dark grey), and 
EC (black), in comparison with untreated control (white). * p<0.05 vs control (negative difference), $ p<0.05 
vs control (positive difference) 
15 
 
 
Fig. 3 Viability of detached HRP after EV stimulation (TUNEL assay) a) positive control (HRP treated with 
DNase); b) negative control (untreated HRP culture); c) HRP detached from cultures following EV stimulation 
and re-seeded in new wells 
 
 
 
Fig. 4 EV increase blood-barrier permeability a) time-course permeability of EC/HRP co-cultures on 
transwell inserts, after EV stimulation; b) permeability after 6 hr exposure. *=p<0.05 vs control without EV, $ 
= p<0.05 vs cultures treated with NG-EV 
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Fig. 5 EV enhance in vitro formation of vessel-like structures by HRP/EC co-cultures a) quantitative 
analysis of newly-formed vessel-like structures after 48 hr EV incubation, percentages of untreated control. * 
p<0.05 vs control, $ p<0.05 vs HG-EV. b-h) vessel-like structure formation by EC/HRP co-cultures: b) HRP 
alone; c) EC alone; d) untreated HRP/EC co-cultures (ctrl no EV); e) NG-EV; f) HG-EV, g) NG hypo-EV; h) 
HG hypo-EV 
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Fig. 6 EV action on HRP is mediated by MMP-2 a) representative zymography of EV showing active MMP-
2 (62 kDA) expression; b) comparison of MMP-2 content between MSC- and EC-derived EV; c) quantitative 
analysis of band densities after zymography of HRP supernatants following EV stimulation and image of one 
representative gel; d) comparative zymography of HRP supernatants following stimulation with MSC- and 
EC-derived EV; e) HRP number after exposure to NG-EV, HG-EV, NG hypo-EV, HG hypo-EV with (grey 
bars) or without (white bars) pre-incubation with the MMP inhibitor batimastat, percentages of untreated 
control * = p<0.05 vs ctrl noEV, $ = p<0.05 vs correspondent EV without batimastat; f-g) batimastat does not 
impede EV internalization into pericytes: HRP incubated for 2 hrs with EV (f) and batimastat pre-treated EV 
(g) 
